NCT03962543 2026-04-08ReNeuSpringWorks Therapeutics, Inc.Phase 2 Active not recruiting114 enrolled 25 charts 3 FDA
NCT00924196 2026-03-20Natural History Study of Patients With Neurofibromatosis Type INational Institutes of Health Clinical Center (CC)Active not recruiting259 enrolled